Sample Exhibits 

For the NIAMS 

Resource-based 

Center Applications 

for Funding in FY2024 

National Institute of Arthritis and 

Musculoskeletal and 

Skin Diseases 

National Institutes of Health 

January 2023
1 

TABLE OF CONTENTS 

INTRODUCTION 2 

EXHIBIT I – Grants Supporting the Research Community 3 

EXHIBIT II – Use of Resource Cores 4 

EXHIBIT III – Sample of Information Useful to Reviewers 5 
2 

SAMPLE EXHIBITS FOR RESOURCE-BASED CENTER APPLICATIONS

NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES 

INTRODUCTION 

This document provides suggested formats for exhibits to be included in the NIAMS Resourcebased Center (P30) Program applications for funding in FY2024. Applications for Resourcebased Centers are sought through Requests for Applications (RFAs), and the topic areas for the 

focus of the Resource-based Center are listed in each RFA. These exhibits apply to the NIAMS

Resource-based Center (P30) RFAs announced in 2023 for funding in FY2024. Research 

objectives, required components, application instructions, review criteria, reporting requirements 

and other information are included in the RFA: 

NIAMS Skin Biology and Diseases Resource-based Centers (P30- Clinical Trial NOT Allowed). 

RFA-AR-24-001 

NIAMS Resource-based Centers for Bone, Muscle, and Orthopaedic Research (P30- Clinical 

Trial NOT Allowed). RFA-AR-24-002 
3 

EXHIBIT I -- Grants Supporting the Research Community 

Sample of Suggested Format 

Supporting 

Organization & 

Grant Number 

Key Personnel Title Project Period Current Annual 

Amount (direct costs) 

NIH 5 R01 AR###### Doe, John (PI) New Therapeutic Agents 

for Autoimmune Disease 3/1/2020 – 2/28/2025 $467,000

TOTAL 
4 

EXHIBIT II -- Use of Resource Cores 

Sample of Suggested Format 

____________________________________________________________________________________________________________

CORE: NAME

Determinations/Services Rendered 

A.

B.

Funded Projects with Period of Estimated Use 

Users Identifying Number Core Use Determinations/Services & Comments 

1.

2.

3.

____________________________________________________________________________________________________________

EXAMPLE 

____________________________________________________________________________________________________________ 

CORE: Cell Culture 

Determination/Services Rendered 

A. Fibroblast Cell Cultures

B. Cell Isolations

C. Special Media Preparation

D. Isotopic Labeling

Funded Projects with Period of Determinations/Services Estimated Use 

Users Identifying Number Core Use A B C D & Comments 

1. J.F. Smith R01AR42846-02 3/24 - 2/25 X X B. 4 per mo

C. 15 per mo

2. S.R. Jones K01AR41654-04 6/25 - 5/27 X X A. 2 per mo

D. 6 per mo

____________________________________________________________________________________________________________
5 

EXHIBIT III-- Sample of Information Useful to Reviewers 

Sample of information useful to reviewers in evaluating a core. This example was developed for a tissue acquisition core. 

I. What types of samples are needed?

A. Diseases

B. Numbers of samples

C. Source of samples

D. Age

E. Sex

F. Tissues

II. What patient population is available? Is it sufficient?

III. What tissues are potentially available?

A. Neonatal foreskins

B. Surgical specimens of normal skin

IV. Ability to communicate needs with clinicians:

A. Is there regular contact between the core director and clinicians? A Ph.D. core director may be less desirable

because of lack of patient contact and lack of regular contact with clinicians, especially clinicians not part of the research

effort.

B. How will needs be communicated to clinicians, especially residents and clinicians not engaged in research?

V. Ability to harvest tissues and transport tissues and supplies:

A. Who will harvest tissues? (Same clinician who sees patients in a busy clinical setting; residents; designated member

of the tissue acquisition core?)

B. Will these be biopsies required for patient care or will the biopsies be only for research purposes? Is it feasible to

expect additional biopsies to be performed in a busy clinic?

C. How will the clinicians obtain special supplies required for harvesting certain tissues (flash freezing or special

fixatives for electron microscopy)? Who will either transport these supplies to the clinic or maintain a stock in the

clinic?

D. Who will transport tissues to the core? This is especially critical with frozen tissues and tissues requiring viability.

VI. Proof of previous ability to obtain similar samples:

A. Publications and preliminary data demonstrating success at sample collection.

B. Is it necessary to pay donors?

Justify budget and required technician effort by estimating volume of samples and slides.